Outcomes of frontolateral vertical partial laryngectomy in T1b glottic carcinomas
- PMID: 32940106
- DOI: 10.1080/00016489.2020.1816659
Outcomes of frontolateral vertical partial laryngectomy in T1b glottic carcinomas
Abstract
Background: The treatment of T1b glottic carcinomas with invasion of the anterior commissure (AC) is still a challenge in larynx oncology. The diversity in treatment protocols is due to the difficulty in achieving safety margins of resection, especially in the AC.
Objective: The treatment success rate of frontolateral vertical partial laryngectomy (FVPL) for the treatment of stage T1b squamous cell carcinoma of the glottic larynx infiltrating the AC.
Material and methods: Clinical data of patients, who were diagnosed with stage T1b squamous cell carcinoma of the glottic larynx and who underwent a FVPL from 01/2003 to 12/2016 in our ENT clinic were retrospectively evaluated. Clinical and oncological outcomes were analyzed.
Results: 39 patients were included in this study. The mean follow-up duration was 79.95 ± 20.59 months. Intraoperative R0 resection was achieved in all patients. In 33.3% patients, documented complications were tissue granulation and synechia formation in the glottic area. The 5-year recurrence-free survival was 82.1%, the 5-year overall survival rate 97.4%, and the 5-year laryngeal preservation rate 94.8%.
Conclusion: Our clinical data demonstrate that T1b glottic carcinomas with invasion of the AC can be effectively treated with FVPL. The outcome is similar to other methods such as transoral laser microsurgery, supracricoidal partial laryngectomy, and radiotherapy.
Keywords: Squamous cell carcinoma; T1b; anterior commissure AC; frontolateral vertical partial laryngectomy FVPL; glottic larynx.
Similar articles
-
Middle frontal horizontal partial laryngectomy (MFHPL): a treatment for stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure.PLoS One. 2013;8(1):e52723. doi: 10.1371/journal.pone.0052723. Epub 2013 Jan 9. PLoS One. 2013. PMID: 23326350 Free PMC article.
-
Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery.Auris Nasus Larynx. 2019 Apr;46(2):285-293. doi: 10.1016/j.anl.2018.08.015. Epub 2018 Sep 11. Auris Nasus Larynx. 2019. PMID: 30217617
-
Radiotherapy or surgical treatment of early glottic carcinoma: A population-based study from the Swedish Head and Neck Cancer Register evaluating primary treatment outcomes for patients with T1a/T1b tumors.Cancer. 2025 Jul 1;131(13):e35955. doi: 10.1002/cncr.35955. Cancer. 2025. PMID: 40569651 Free PMC article.
-
Transthyrohyoid access to the larynx for endoscopic resection of early-stage glottic cancer.Head Neck. 2016 Aug;38(8):1286-9. doi: 10.1002/hed.24473. Epub 2016 Apr 15. Head Neck. 2016. PMID: 27080920 Review.
-
Laser Microsurgery Versus Radiotherapy Versus Open Partial Laryngectomy for T2 Laryngeal Carcinoma: A Systematic Review of Oncological Outcomes.Ear Nose Throat J. 2021 Feb;100(1_suppl):51S-58S. doi: 10.1177/0145561320928198. Epub 2020 Jun 8. Ear Nose Throat J. 2021. PMID: 32511005
Cited by
-
Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery.Clin Exp Otorhinolaryngol. 2025 May;18(2):89-108. doi: 10.21053/ceo.2025.00009. Epub 2025 Apr 8. Clin Exp Otorhinolaryngol. 2025. PMID: 40199514 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous